These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 21659749)

  • 61. [Immunomodulation for sepsis: a change of tack?].
    Leentjens J; Kox M; Pickkers P
    Ned Tijdschr Geneeskd; 2014; 158():A6859. PubMed ID: 24518844
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Immunodepression in sepsis and SIRS assessed by ex vivo cytokine production is not a generalized phenomenon: a review.
    Cavaillon JM; Adib-Conquy M; Cloëz-Tayarani I; Fitting C
    J Endotoxin Res; 2001; 7(2):85-93. PubMed ID: 11521088
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Mediators of systemic inflammatory response syndrome and the role of recombinant activated protein C in sepsis syndrome.
    Kak V
    Infect Dis Clin North Am; 2011 Dec; 25(4):835-50. PubMed ID: 22054759
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Anti-inflammatory therapy in sepsis].
    Briegel J; Weis F; Kilger E
    Chirurg; 2003 Jun; 74(6):590-1; author reply 591-2. PubMed ID: 12916500
    [No Abstract]   [Full Text] [Related]  

  • 65. The systemic inflammatory response syndrome.
    Robertson CM; Coopersmith CM
    Microbes Infect; 2006 Apr; 8(5):1382-9. PubMed ID: 16679040
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Evolving strategies in the treatment of sepsis and systemic inflammatory response syndrome (SIRS).
    Horn KD
    QJM; 1998 Apr; 91(4):265-77. PubMed ID: 9666949
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of sepsis and systemic inflammatory response syndrome on neonatal hearing screening outcomes following gentamicin exposure.
    Cross CP; Liao S; Urdang ZD; Srikanth P; Garinis AC; Steyger PS
    Int J Pediatr Otorhinolaryngol; 2015 Nov; 79(11):1915-9. PubMed ID: 26384832
    [TBL] [Abstract][Full Text] [Related]  

  • 68. HMGB1 as a therapeutic target for sepsis: it's all in the timing!
    Gentile LF; Moldawer LL
    Expert Opin Ther Targets; 2014 Mar; 18(3):243-5. PubMed ID: 24479494
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Injury, sepsis, and the regulation of Toll-like receptor responses.
    Murphy TJ; Paterson HM; Mannick JA; Lederer JA
    J Leukoc Biol; 2004 Mar; 75(3):400-7. PubMed ID: 14557385
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Alert cell strategy: mechanisms of inflammatory response and organ protection.
    Hatakeyama N; Matsuda N
    Curr Pharm Des; 2014; 20(36):5766-78. PubMed ID: 25229471
    [TBL] [Abstract][Full Text] [Related]  

  • 71. SIRT1 regulates inflammation response of macrophages in sepsis mediated by long noncoding RNA.
    Jia Y; Li Z; Cai W; Xiao D; Han S; Han F; Bai X; Wang K; Liu Y; Li X; Guan H; Hu D
    Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):784-792. PubMed ID: 29277325
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Sepsis in the critically-ill patient].
    Christensen VB; Nielsen JS; Tønnesen EK
    Ugeskr Laeger; 2007 Feb; 169(8):703-5. PubMed ID: 17313921
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Biomarkers in critically ill patients with systemic inflammatory response syndrome or sepsis supplemented with high-dose selenium.
    Brodska H; Valenta J; Malickova K; Kohout P; Kazda A; Drabek T
    J Trace Elem Med Biol; 2015; 31():25-32. PubMed ID: 26004888
    [TBL] [Abstract][Full Text] [Related]  

  • 74. How Clinical Flow Cytometry Rebooted Sepsis Immunology.
    Monneret G; Gossez M; Aghaeepour N; Gaudilliere B; Venet F
    Cytometry A; 2019 Apr; 95(4):431-441. PubMed ID: 30887636
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The role of proteomics in understanding biological mechanisms of sepsis.
    Cao Z; Robinson RA
    Proteomics Clin Appl; 2014 Feb; 8(1-2):35-52. PubMed ID: 24339042
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Current status and prospect of integrative immune-therapy on pyaemia].
    Xiong XD
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Aug; 30(8):802-5. PubMed ID: 21038645
    [No Abstract]   [Full Text] [Related]  

  • 77. Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction.
    Castelli GP; Pognani C; Meisner M; Stuani A; Bellomi D; Sgarbi L
    Crit Care; 2004 Aug; 8(4):R234-42. PubMed ID: 15312223
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Current challenges in understanding immune cell functions during septic syndromes.
    Franks Z; Carlisle M; Rondina MT
    BMC Immunol; 2015 Mar; 16():11. PubMed ID: 25887317
    [TBL] [Abstract][Full Text] [Related]  

  • 79. New insights into cellular mechanisms during sepsis.
    Hoesel LM; Gao H; Ward PA
    Immunol Res; 2006; 34(2):133-41. PubMed ID: 16760573
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Molecular and cellular aspects of sepsis-induced immunosuppression.
    Wang TS; Deng JC
    J Mol Med (Berl); 2008 May; 86(5):495-506. PubMed ID: 18259721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.